RESUMEN
Moya Moya disease is a rare cause of stroke in adults, and is a rarity secondary to hepatitis C virus infection (HCV) and cryoglobulinemia (CG). We report such a rare association in a young patient who presented with intracerebral hemorrhage.
Asunto(s)
Adulto , Hemorragia Cerebral Traumática/etiología , Crioglobulinemia/complicaciones , Hepatitis C/complicaciones , Humanos , Masculino , Enfermedad de Moyamoya/complicaciones , Accidente Cerebrovascular/etiologíaRESUMEN
Thrombocytosis is a common clinical condition. Drugs used for thrombocytosis are hydroxy urea, alkylating agents and interferon alpha. We are reporting a case of chronic myeloid leukemia with thrombocytosis who did not respond to hydroxy urea but was controlled with the addition of a new drug anagrelide. Anagrelide is a platelet reducing agent with no serious side effects. It may be the main weapon against thrombocytosis associated with chronic myeloid leukaemia (CML) and essential thrombocytosis in the coming years.